InterCure Ltd. (TLV:INCR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 518.90
-4.80 (-0.92%)
Apr 1, 2025, 4:47 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 246.99 million as of April 1, 2025. Its market cap has decreased by -19.07% in one year.
Market Cap
246.99M
Enterprise Value
379.18M
Revenue
272.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
518.90
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 246.99M, an increase of 3,753.98%. That is a compound annual growth rate of 29.10%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 65.58B |
| Danel (Adir Yeoshua) | 2.20B |
| Kamada | 1.41B |
| Bait Bakfar | 960.19M |
| Novolog (Pharm-Up 1966) | 813.77M |
| Ilex Medical | 700.98M |
| BrainsWay | 637.11M |
| SofWave Medical | 564.43M |